Literature DB >> 36060385

Just When We Thought That COVID Was Over: A Systematic Review.

Maha Tariq1, Maitri V Acharekar1, Sara E Guerrero Saldivia1, Sumedha Unnikrishnan1, Yeny Y Chavarria1, Adebisi O Akindele1, Ana P Jalkh1, Aziza K Eastmond1, Chaitra Shetty1, Syed Muhammad Hannan A Rizvi1, Joudi Sharaf1, Kerry-Ann D Williams1, Prachi Balani1.   

Abstract

As the globe continues to grapple and scuffle with new emerging strains of COVID every day, a set of recovered patients continue to show persistent enervating symptoms. Many patients never fully recovered after COVID and had neurological and psychiatric symptoms for weeks or months. The emphasis of our study is on these long haulers, particularly on the two critical organ systems of the body, i.e., the central nervous system and the muscular system. Depending upon the severity of the disease, many signs and symptoms continue to linger, ranging from weeks to months. A total of 29 studies are included in our review after thorough screening, application of inclusion and exclusion criteria, and quality appraisals. The total number of patients included is 6012. We found many long-term effects, but the emphasis of our study continued to remain on the two main organ systems that resulted in prolonged COVID with debilitating symptoms and thus affected the quality of life of these patients. Various factors and underlying pathophysiologic manifestations result in the predominance of these signs and symptoms. Furthermore, the patient's underlying medical conditions and other environmental factors may add to it. More focus is required on the quality of life post-COVID, and this requires a team of specialists. There are still many unanswered questions like which ethnicity is affected more, why females are more prone to the long symptoms, and the effects of various treatments on the long-term signs and symptoms.
Copyright © 2022, Tariq et al.

Entities:  

Keywords:  chronic fatigue; covid 19; muscle aches; physical medicine and rehabilitation; primary headaches

Year:  2022        PMID: 36060385      PMCID: PMC9420529          DOI: 10.7759/cureus.27441

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction and background

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel RNA β- coronavirus that causes COVID-19, started in late 2019, affecting millions of lives and causing a huge burden on the economy and physical wellbeing [1,2]. The virus, which was formerly known to affect the lungs and cause respiratory illness, in actuality affects multiple organs of the human body, causing various signs and symptoms [2,3]. A staggering number of patients experienced long-standing symptoms even after they were tested negative for the disease; due to this fact, it is referred to as long-COVID [1]. The most common symptoms experienced include; fatigue, headache, cognitive impairments, weakness, myalgia, poor concentration, and sleep disturbances [3-6]. The most likely mechanism through which this virus enters the brain is the angiotensin-converting enzyme receptor, thus causing profuse cytokine syndrome resulting in damage to the cells [4]. Apart from cytokine syndrome, autoantibodies against various body cells and autonomic nervous system disruption lead to post-viral illness [4,6]. The purpose of our study is to focus on the two main long-standing symptoms, fatigue and headaches, resulting in poor work performance and difficulty in performing daily activities of life. Methods We obeyed the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) guidelines for conducting our systematic review (Figure 1) [7].
Figure 1

PRISMA flow chart

 PRISMA: Preferred Reporting Items for Systematic Review and Meta Analysis, MeSH: Medical Subject Heading, SANRA: scale for quality assessment of narrative review articles, PMC: PubMed Central

PRISMA flow chart

PRISMA: Preferred Reporting Items for Systematic Review and Meta Analysis, MeSH: Medical Subject Heading, SANRA: scale for quality assessment of narrative review articles, PMC: PubMed Central We systematically searched multiple electronic databases, such as PubMed, PubMed Central (PMC), and Medline, for data collection. We explored the databases by using terms of medical topics and by Medical Subject Headings (MeSH) words. The keywords used are “migraine,” “new-onset headache,” “exacerbation of headache,” “chronic fatigue syndrome,” “post-viral syndrome,” “lack of energy,” “exhaustion,” “fatigue,” “COVID19”, ”COVID recovered patients” and ”long term complications,” separately and in combination to find relevant studies. The total number of articles found in electronic databases is 509. Inclusion and exclusion criteria For our research, we included all the articles in English. Full free texts from the last three years were included. Studies that we included are clinical trials, randomized control trials, meta-analyses, and systematic and traditional reviews. Studies include humans only from age 18 and above. Studies done before 2019, gray literature, books, documents, and duplicates were excluded from the study. Results A total of 509 studies were obtained from the databases. Records were analyzed on the basis of title, abstract, and application of inclusion and exclusion criteria. A total of 182 studies were obtained. After the removal of duplicates, we were left with 178 studies. All the articles were further screened on the bases of title, abstract, and quality check; a total of 29 studies were left. The total number of patients included in the studies was 6012. Clinical trials were screened through the Cochrane risk bias assessment tool, observational studies by the Newcastle-Ottawa Scale, systematic and meta-analyses by PRISMA, and literature review by the scale for quality assessment of narrative review articles (SANRA) checklist.

Review

The pathophysiology of coronavirus Coronavirus is a single-stranded ribonucleic acid (RNA) virus with projections of glycoproteins on the outer surface. The main structure is composed of many proteins, with four proteins being the most important integral constituents, namely spike protein, M protein, nucleocapsid N glycoprotein, and E protein [4]. This virus gains entry into the human body through the nasal route. Once inside the body, it binds to the receptor named angiotensin-converting enzyme 2 (ACE2). As these receptors are located in the various cells of the body, this disease presents with a wide array of signs and symptoms [8]. This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or coronavirus disease (COVID-19), depending on its persistence of signs and symptoms, is classified as post-acute, with signs and symptoms ranging from about less than a month, and chronic, with signs and symptoms lasting for more than three months [1]. It has been seen that some patients who are recovered from COVID-19 still experience varying symptoms like fatigue, long-standing headaches, impaired cognition, generalized malaise, various psychiatric conditions, and many more. Therefore, this long-standing trail of symptoms is referred to as long COVID [5]. According to a study, T-cell dysfunction may be linked to the pathophysiology of long COVID, as seen in various autoimmune diseases. One of the mechanisms behind the pathophysiology of COVID-19 affecting other organs besides the lungs is the formation of antigen-antibody complexes, activating the humoral immune response [1]. Figure 2 shows the structure of the virus, how COVID-19 has affected various body organs, and what its various long-term residual symptoms are.
Figure 2

Structure of the virus and its effects on the body

RNA: ribonucleic acid, ALT: alanine aminotransferase, AST: aspartate aminotransferase.

Image created using Microsoft Powerpoint (Microsoft, Redmond, Washington)

Structure of the virus and its effects on the body

RNA: ribonucleic acid, ALT: alanine aminotransferase, AST: aspartate aminotransferase. Image created using Microsoft Powerpoint (Microsoft, Redmond, Washington) Effect on the central nervous system (CNS) The virus gains entry into the brain through the olfactory bulb. The blood-brain-barrier (BBB) has ACE-2 receptors on the endothelial cells resulting in the viral entry into the nervous system, thus causing various signs and symptoms. The virus causes inflammation of the brain through a mechanism called cytokine storm syndrome. Cytokine storm syndrome causes the percolation of various inflammatory cells resulting in increased amounts of cytokines, thus causing inflammation of the brain [1]. Apart from direct damage caused by the virus to the brain, tissue hypoxia and edema also leads to brain damage, as these findings were seen in the autopsy of patients deceased due to COVID-19 [1]. According to one of the studies, hypoxia leads to damage to the mitochondria, thus causing brain fog, i.e., altered cognition. Neurological signs and symptoms of COVID-19 include headache, vomiting, brain fog, fatigue, behavioral problems, vertigo, loss of sense of taste and smell, and various psychiatric conditions; all of these conditions are referred to as neuro-COVID [1,8,9-12]. From all the studies which we have included in our review, headache is the most prevalent neurological complaint lasting from days to weeks post recovery. The chain of reactions occurring after the virus enters the body is shown in Figure 3
Figure 3

Entry of virus in the cell and chain of events following virus entry

ACE-II: angiotensin-converting enzyme 2, IL: interleukin, TNF: tumor necrosis factor, INF: interferon, Ig: immunoglobulin

Figure created using Microsoft Powerpoint (Microsoft, Redmond, Washington)

Entry of virus in the cell and chain of events following virus entry

ACE-II: angiotensin-converting enzyme 2, IL: interleukin, TNF: tumor necrosis factor, INF: interferon, Ig: immunoglobulin Figure created using Microsoft Powerpoint (Microsoft, Redmond, Washington) Effect on the peripheral muscles and mechanism of weakness and fatigue One of the most important complications of COVID-19 is muscle weakness and unbearable fatigue. The presence of ACE-2 receptors on the skeletal muscles is the reason why skeletal muscles are affected by COVID-19 and thus present with continuing body aches. The muscle weakness could be due to the disease itself, whereas the sedentary mode of life due to the pandemic, long bed rest, and calorie deficit diet during the illness also contributed to the development of muscle weakness [8]. According to a study, brain fog, stringent fatigue, and other long-standing complaints of long COVID mirror myalgic encephalopathy or chronic fatigue syndrome, which develops after a viral infection [13]. Some studies have found autoantibodies against various cell lines and receptors aid in the austerity of symptoms. Along with that, involvement of the autonomic nervous system also pitches in the clinical picture of long COVID [10]. All this has led to poor quality of life. COVID-19 recovered patients cannot cope with daily activities and need help in carrying out their basic tasks. Rehabilitation is required for these patients so that they can return to their pre-COVID physical fitness level. Rehab includes a multifaceted approach which includes aerobic exercises, breathing exercises, proper sleep hygiene, and help with proper meal planning [9,10]. The use of multivitamins and as-needed analgesics for minor signs and symptoms of long COVID can also be helpful. Figure 4 explains how inflammation occurs in the muscle after being affected by the virus.
Figure 4

Muscle inflammation caused by the virus

 ACE-II: angiotensin-converting enzyme-2, IL: interleukin, TNF: tumor necrosis factor

Image created using Microsoft power point (Microsoft, Redmond, Washington), [14]

Muscle inflammation caused by the virus

ACE-II: angiotensin-converting enzyme-2, IL: interleukin, TNF: tumor necrosis factor Image created using Microsoft power point (Microsoft, Redmond, Washington), [14] A list of all the studies included in the review is shown in Table 1.
Table 1

List of all the studies included in the review

ACE: angiotensin-converting enzyme, ANS: autonomic nervous system, CNS: central nervous system, N/A: number of patients not mentioned in the study

 Author and yearType of studyPatientsPurpose of studyResultsConclusion
Ahmad et al. [1], 2021Systematic reviewN/AThe long-term effects of COVID in recovered patientsCOVID affects almost all the vital organs through antibody-mediated mechanismA thorough clinical evaluation of COVID patients is required in order to fully understand its long-term effects
Michelen et al. [2], 2021Systematic reviewN/AThe effects of long-standing COVID on different populationsMost common signs and symptoms of COVID include weakness, fatigue, impaired concentration, difficulty breathing, and abnormal lung function testsLong COVID effects with wide variety of ongoing symptoms
Becker et al. [3], 2021ReviewN/AAutonomic nervous system dysregulation due to COVIDResting increased heart rate, fatigue, and sleep disturbances could be due to disturbances in the autonomic nervousLong-term fatigue and reduced exercise stamina could be a result of disruption of ANS
Nagu et al. [4], 2021ReviewN/AEffect of COVID on CNSWide array of population had CNS involvementCOVID can lead to multiple effects on the CNS
Butler et al. [5], 2022ReviewN/AEffects of COVID on the nervous system and cognitionDelirium is the most common neuropsychiatric complication of COVIDCOVID has a great impact on cognition and nervous system function
Tirelli et al. [6], 2021Clinical trial / multicenter study100      Use of ozone therapy to treat post-COVID fatigueOut of 100 patients, about 67 people benefited from the therapyOzone therapy can be used as a treatment agent
Korompoki et al. [8], 2021ReviewN/ALong-term effects of COVID on different body organsCOVID has lead to a wide array of signs and symptomsAlmost all the organs of the body are affected by COVID
Stefano et al. [9], 2021Review/Historical articleN/ANeurologic and psychiatric signs and symptoms in COVID as compared to past pandemicsLong COVID sequelae are similar in regards to chronic fatigue from other viral infectionsChronic fatigue syndrome occurs as a result of viral infections
Reza-Raldivar et al. [10], 2020ReviewN/APathogenicity of COVID and how it affects CNSCOVID affects CNS and it enters through various routesCNS involvement can lead to chronic signs and symptoms in patients recovered from COVID
Komaroff et al. [11], 2021ReviewN/A How post-COVID is similar to myalgic encephalomyelitisAutoantibody formation against various cell lines can be the cause of post-COVID severity of diseaseLong-term effects of COVID on the body may be due to the damage caused to the vital organs or the psychological insult due to the pandemic
Yong et al. [12], 2021ReviewN/AThe sequelae of long-standing COVID infectionLong  COVID may be due to dysfunction of T and B cellsLong COVID is a serious problem that needs to be addressed
Akbarialiabad et al. [13], 2021Systematic reviewN/AUnderstanding the effect of long COVIDAll vital organs are affected due to COVID, still need a proper definition of the long COVIDCOVID effects multiple organs of the body resulting in long-term effects
Raveendran et al. [14], 2021ReviewN/ADefining what long COVID is and its long-standing symptomsFatigue, respiratory symptoms, loss of concentration, and body aches constitute LONG COVIDHow we can tackle this long COVID
Desai et al. [15], 2021ReviewN/AStudy the involvement of different body organs in COVIDMore data is required as the virus is changing its strains rapidlyInvolvement of various organs occurs in COVID
Yang et al. [16], 2021ReviewN/ACNS insult caused by COVIDCOVID causes a wide variety of signs and symptoms, CNS involvement is the most commonCOIVD gains entry by ACE, neural transport, and through hematogenous route, causing multiple signs and symptoms
Lopez-Leon et al. [17], 2021Meta-analysisN/AEffects of COVID in chronic casesAlmost all major organs are affected by COVIDCOVID causes a wide variety of long-standing effects on the human body
Systematic review
Dennis et al. [18], 2021Observational study201      To study the extent of organ damage in patients who contracted COVIDMultiple organs were affected as a result of COVIDPatients with less severity of disease experience at least one organ dysfunction for at least a couple of months.
Bougakov et al. [19], 2021ReviewN/AHow COVID affects the nervous systemVirus uses different mechanisms to enter the brain, thus causing long-standing effects like headache, cognitive impairment, and many more symptomsCOVID affects CNS causing a wide array of signs and symptoms
Agergaard et al. [20], 2021Clinical trial23      Effect of COVID on the muscles and nervesThe study showed muscle changes post COVIDCOVID can affect multiple organs including the muscles, thus leading to fatigue and weakness
Banerjee et al. [21], 2020ReviewN/AEffects of COVID on the brain and psychological healthCOVID causes a wide variety of signs and symptoms on the CNSCOVID can present in various ways like headache, loss of taste and smell, causing various psychological signs and symptoms
Yong et al. [22], 2021ReviewN/AHow COVID affects brainstemBrain stem dysfunction maybe be linked to the long COVID syndrome, still a hypothesisBrainstem dysfunction could be related to the chronic effects of COVID on the body
Asadi-Pooya et al. [23], 2021Observational study4681   What factors lead to chronic COVIDStudy showed that the extent of the disease depends on the sex of the patient, the presence and absence of respiratory symptoms, and the days spent in the hospitalLong-standing COVID is associated with various signs and symptoms and it depends on various factors, the most important being the sex of the patient, the presence of pulmonary symptoms
Kirwan et al. [24], 2020ReviewN/AMuscle loss in long-standing COVIDCOVID has lead to effects on various organs of the body including muscles, leading to muscle lossSpending more time indoors leads to an increased buildup of fats and decreased physical activity
Romero-Duarte et al. [25], 2021Observational study969    Long-term symptoms and the fate of patients recovered from COVIDPatients recovered from COVID experienced multiple signs and symptoms ranging from mild to severe on the basis of severitySteps can be taken to prevent the long-term effects in patients who tested positive for COVID so that they can be prevented from the long-standing effects
Alam et al. [26], 2021ReviewN/ACOVID can lead to effects on the CNSCNS is being affected by COVID causing multiple signs and symptomsWork should be done  on COVID to find out its effects on the CNS
Van Herck et al. [27], 2021Clinical study239      Persistent fatigue in patients with long COVIDOut of all the patients, females had more signs and symptoms of fatigue post-COVIDFatigue is the most common long-term manifestation of COVID affecting both physical and the mental health
Adeloye et al. [28], 2021ReviewN/AEffects of long COVID in patients with respiratory diseases both new and old conditionsPatients with underlying respiratory diseases may have more effects of COVID on their body Underlying respiratory diseases could lead to long-term effects of COVID on the body
Fisicaro et al. [29], 2021ReviewN/AInvolvement of nervous system in COVIDEvidence is still not clear on the basis of Histo-pathological findings from brain tissues as very few subjects showed the evidenceMore studies showed be carried out to find the accurate association between COVID  and its effect on the tissues on the body
Silva Andrade et al. [30], 2021ReviewN/AComplications due to long COVIDAll major organs are affected by COVIDThrombosis, neurologic, pulmonary, gastrointestinal, skin, and muscular tissues all are affected by COVID

List of all the studies included in the review

ACE: angiotensin-converting enzyme, ANS: autonomic nervous system, CNS: central nervous system, N/A: number of patients not mentioned in the study Limitations As this disease is still new, we have a lot to learn. Most of the studies showed the prevalence of long COVID symptoms in people already with psychiatric disorders, and it is more prevalent in the female population; this creates bias of whether there was any association with the body physique or hormonal changes that contributed to this finding, or if the prevalence of more autoimmune diseases in females lead to these symptoms. More evidence is required to show the association between autoimmune diseases and COVID-19. In order to assess fatigue, there is a need for a standard questionnaire, which should be used to grade fatigue without bias. The role of steroid use in patients with severe COVID-19 needs attention. As corticosteroids can disrupt the cytokine storm, resulting in reduced signs and symptoms, no clear evidence was found that showed whether fatigue still persists in patients who used steroids. We still do not have enough data showing which ethnicity is more affected. We still do not have enough data showing which ethnicity is affected more and the role of antibodies in the severity of acute disease. More information is needed regarding the type of antibody that is more prevalent in causing these long COVID signs and symptoms. Information from primary care providers could be an asset in collecting statistics on long-term signs and symptoms and following up with patients. There is a need for more observational studies, case reports, and case series to answer all these questions thoroughly.

Conclusions

This virus is still a challenge as it is evolving into different variants with every coming day. Vaccines are out there, and the general population needs to be counseled on the benefits of the vaccine as it can not only prevent the need for hospitalizing but also it can help in preventing patients from going into the long sequelae requiring bed rest and thus causing muscle wasting and severe debilitating fatigue. The toll on the body post-COVID is both mental and physical. A team of specialists, including physical therapists, nutritionists, primary care providers, nurses, and home care attendants, needs to work hand in hand to provide the best care for this group of people, especially the elderly. They need counseling, physical rehabilitation, regular physical therapy sessions, and of course, nutrient-rich diets to ensure that these groups of people can resume their daily activities of living without depending on someone and can enjoy life to the fullest.
  30 in total

Review 1.  The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.

Authors:  Davies Adeloye; Omer Elneima; Luke Daines; Krisnah Poinasamy; Jennifer K Quint; Samantha Walker; Chris E Brightling; Salman Siddiqui; John R Hurst; James D Chalmers; Paul E Pfeffer; Petr Novotny; Thomas M Drake; Liam G Heaney; Igor Rudan; Aziz Sheikh; Anthony De Soyza
Journal:  Lancet Respir Med       Date:  2021-08-17       Impact factor: 30.700

Review 2.  Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System.

Authors:  Edwin Estefan Reza-Zaldívar; Mercedes Azucena Hernández-Sapiéns; Benito Minjarez; Ulises Gómez-Pinedo; Ana Laura Márquez-Aguirre; Juan Carlos Mateos-Díaz; Jorge Matias-Guiu; Alejandro Arturo Canales-Aguirre
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

Review 3.  Long COVID: An overview.

Authors:  A V Raveendran; Rajeev Jayadevan; S Sashidharan
Journal:  Diabetes Metab Syndr       Date:  2021-04-20

Review 4.  Emerging Knowledge of the Neurobiology of COVID-19.

Authors:  Matthew Butler; Benjamin Cross; Danish Hafeez; Mao Fong Lim; Hamilton Morrin; Emma Rachel Rengasamy; Tom Pollak; Timothy R Nicholson
Journal:  Psychiatr Clin North Am       Date:  2021-11-11

Review 5.  Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page series.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2021-08-17       Impact factor: 2.300

6.  Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.

Authors:  Andrea Dennis; Malgorzata Wamil; Johann Alberts; Jude Oben; Daniel J Cuthbertson; Dan Wootton; Michael Crooks; Mark Gabbay; Michael Brady; Lyth Hishmeh; Emily Attree; Melissa Heightman; Rajarshi Banerjee; Amitava Banerjee
Journal:  BMJ Open       Date:  2021-03-30       Impact factor: 2.692

7.  Characterising long COVID: a living systematic review.

Authors:  Lakshmi Manoharan; Natalie Elkheir; Vincent Cheng; Andrew Dagens; Melina Michelen; Claire Hastie; Margaret O'Hara; Jake Suett; Dania Dahmash; Polina Bugaeva; Ishmeala Rigby; Daniel Munblit; Eli Harriss; Amanda Burls; Carole Foote; Janet Scott; Gail Carson; Piero Olliaro; Louise Sigfrid; Charitini Stavropoulou
Journal:  BMJ Glob Health       Date:  2021-09

Review 8.  Long COVID, a comprehensive systematic scoping review.

Authors:  Hossein Akbarialiabad; Mohammad Hossein Taghrir; Ashkan Abdollahi; Nasrollah Ghahramani; Manasi Kumar; Shahram Paydar; Babak Razani; John Mwangi; Ali A Asadi-Pooya; Leila Malekmakan; Bahar Bastani
Journal:  Infection       Date:  2021-07-28       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.